IDEAYA Biosciences Announces Submission of IND Application to the U.S. FDA for PARG Development Candidate IDE161

December 12, 2022

Biotechnology

Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024

May 8, 2024
Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study

May 8, 2024
Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules

May 7, 2024
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement

May 7, 2024